- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Eyepoint Pharmaceuticals Inc.
Headquarters: Watertown, MA, United States of America
Website: http://www.eyepointpharma.com...
Year Founded: 2000
Status: Public
Industry Sector: HealthTechnology
CEO: Jay S. Duker, MD
Number Of Employees: 165
Enterprise Value: $71,612,100
PE Ratio: -2.95
Exchange/Ticker 1: NASDAQ:EYPT
Exchange/Ticker 2: N/A
Latest Market Cap: $469,417,696
BioCentury | Nov 1, 2024
Finance
How Fairmount’s Paragon incubator steered two more companies to NASDAQ
In BioCentury’s Public Equity Report: Paragon-backed Jade and Crescent each reverse-merging with public companies, raising combined $500M
BioCentury | May 7, 2024
Product Development
Clinical report: Calliditas data provide mixed support for anti-fibrotic cancer mechanism
Plus: J&J aiming to replace bladder cancer surgery with TAR-210, and updates from Merck, GlycoMimetics, EyePoint and more
BioCentury | Mar 6, 2024
Management Tracks
EyePoint names Ribeiro CMO
Plus: Ford joins Prothena and updates from Atlas, Osmol and CytoVale
BioCentury | Dec 7, 2023
Politics, Policy & Law
Dec. 6 Quick Takes: Pfizer CEO excoriates university presidents on antisemitism failure
Plus: J&J’s Duato: GLP-1 space ‘too crowded’ to enter, Pfizer leaving BIO and updates from Merck KGaA, Pharvaris, Novartis, Arvinas, Seagen, EyePoint and CatalYm
BioCentury | Dec 5, 2023
Product Development
Dec. 4 Quick Takes: EyePoint’s data for Eylea competitor drive big gain
Plus: Seismic adds $121M in series B round and updates from Merck KGaA, Abbisko, Perpetual Medicines, CRISPR Therapeutics and YolTech
BioCentury | Oct 17, 2023
Management Tracks
Allogene named Geoffrey Parker as CFO
Plus: Summit hires Manmeet Soni as COO, and updates from SwanBio, DBV, Lyra and EyePoint
BioCentury | Jul 11, 2023
Management Tracks
Billy Cho joins CBC as senior managing director
Plus: Birchenough becomes chairman of global healthcare at Barclays, and updates from EyePoint, Replicate, MBX, Voyager and more
BioCentury | Jan 5, 2023
Management Tracks
Sanofi’s Sarchi heads to Replimune
Plus: Albers joins Atlas, new CBO at Altimmune and updates from Nuvig, Zymeworks, Fulcrum, Step, Charm, Kymera and more
BioCentury | Mar 9, 2022
Management Tracks
Oxford spinout MiroBio adds Keswani as CMO, promotes Murray to CSO
Plus updates from Centessa, Teon, AnchorDx, Pillar and more
BioCentury | Jan 12, 2022
Management Tracks
Alector’s Robert Paul becomes CEO at Nine Square
Plus Smeal joins Cardiff as CSO and updates from GHIT, Aclaris, Iovance, Pyramid, SomaLogic and more
Items per page:
1 - 10 of 23